Study of the Effect of a Nutritional Supplement on Microbiota, Metabolic Control, Inflammatory Profile, and Quality of Life in Patients With Polycystic Ovary Syndrome.

NARecruitingINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

May 31, 2029

Conditions

Polycystic Ovary SyndromeMetabolic Syndrome

Interventions

DIETARY_SUPPLEMENT

Ovapro (Lifepro)

Dietary supplement that contains inositol, vitamin D, zinc, and curcumin.

Trial Locations (1)

RECRUITING

FISABIO, Valencia

All Listed Sponsors

lead

Celia Bañuls

OTHER